Fractional flow reserve or optical coherence tomography for angiographically intermediate coronary stenoses: 5-year outcomes in the FORZA trial.

The article discusses the results of the FORZA trial, which compared the use of fractional flow reserve (FFR) and optical coherence tomography (OCT) for the management of angiographically intermediate coronary lesions (AICLs). The trial found that both FFR and OCT guidance provided similar rates of major adverse cardiac events (MACE) at the 5-year follow-up. The study suggests that OCT could be a valuable alternative to FFR for the management of patients with AICLs, but further investigation is needed to determine the optimal use of these tools. The article acknowledges the limitations of the study, including a small sample size and unreliable symptom assessment at long-term follow-up. [Extracted from the article]